Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156997 · ClinicalTrials.gov registry record
Extreme Lipids Repository
A clinical trial of Lipoprotein Disorder, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 250
- Enrollment target
- 2
- Study locations
NCT04156997: Active study of Lipoprotein Disorder, sponsored by University of Texas Southwestern Medical Center.
NCT04156997 is a study of Lipoprotein Disorder that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 250 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04156997, a study of Lipoprotein Disorder, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, observational study to establish a repository of samples from patients with extreme lipid phenotypes including but not limited to hyperlipidemia, dyslipidemia, hyperlipoproteinemia, extreme low/high HDL levels and deranged lipoprotein metabolism. The investigators plan to conduct sophisticated composition and functional analyses as well as genetic analysis to better understand the determinants of extreme lipid derangements.
Primary Outcome
Blood samples will be collected for preparation of plasma and serum, extraction of DNA and isolation of circulating cells. Future analysis include genomic, proteomic and metabolomic analysis
Conditions Studied
Interventions
- OTHER No intervention is involved in this study
Study Locations (2)
Texas
- Parkland Health Hospital System - Dallas
- University of Texas Southwestern Medical Center - Ambulatory Clinic - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2029-05 |
What the registry record for NCT04156997 still lists
NCT04156997 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Lipoprotein Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention is involved in this study is the first listed.
NCT04156997 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04156997 about?
NCT04156997 is a clinical study titled "Extreme Lipids Repository". This is a prospective, observational study to establish a repository of samples from patients with extreme lipid phenotypes including but not limited to hyperlipidemia, dyslipidemia, hyperlipoproteinemia, extreme low/high HDL levels and deranged lipoprotein metabolism. The investigators plan to cond...
What is the current status of trial NCT04156997?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2019-05-10. Estimated completion is 2029-05.
What conditions does trial NCT04156997 study?
This clinical trial studies the following conditions: Lipoprotein Disorder.
What interventions are being tested in trial NCT04156997?
The interventions under investigation include: No intervention is involved in this study (OTHER).
Who is sponsoring clinical trial NCT04156997?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04156997 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipoprotein Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI